title: Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
authors.forename: Stephan
authors.initials: S
authors.lastname: von Haehling
authors.forename: Mitja
authors.initials: M
authors.lastname: Lainscak
authors.forename: Stefan D
authors.initials: SD
authors.lastname: Anker
mesh_terms: D001067:Appetite Depressants / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality*; D003503:Cyclobutanes / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D015203:Reproducibility of Results; D015431:Weight Loss
chemical_list: D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine